Evidence map›Paper›PMID 41799908›Full record

ReviewRSC advances2026

A review of commercial and laboratory-based microfluidic devices based on glass and/or silicon substrates.

Avishek Deb, Gnanesh Nagesh, Tyler Harrison, Dean Spicer, David S-K Ting, Mohammed Jalal Ahamed

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Avishek DebMechanical, Automotive and Materials Engineering, University of Windsor ON Canada M.Ahamed@uwindsor.ca.ORCID https://orcid.org/0009-0000-3081-066X
Gnanesh NageshMechanical, Automotive and Materials Engineering, University of Windsor ON Canada M.Ahamed@uwindsor.ca.ORCID https://orcid.org/0000-0002-1554-9747
Tyler HarrisonTeledyne MEMS Edmonton AB Canada.
Dean SpicerTeledyne MEMS Edmonton AB Canada.
David S-K TingMechanical, Automotive and Materials Engineering, University of Windsor ON Canada M.Ahamed@uwindsor.ca.ORCID https://orcid.org/0000-0002-0919-6156
Mohammed Jalal AhamedMechanical, Automotive and Materials Engineering, University of Windsor ON Canada M.Ahamed@uwindsor.ca.ORCID https://orcid.org/0000-0002-3346-6187

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microfluidic devices are increasingly being sought after as powerful alternatives to traditional macroscopic benchtop biochemical analysis systems due to their lower cost, faster analysis times, and reduced reagent consumption. Advances in additive manufacturing and semiconductor fabrication have simplified device realization, enabling their integration into a wide range of biochemical applications. Microfluidic devices were initially fabricated using glass and silicon as substrate materials. However, as the demand for more complex structures has increased, new materials have been introduced. Among these are soft and thermoplastic polymers, which are well suited to techniques such as soft molding, injection molding, and hot embossing. Despite these developments, surface-treated glass and silicon are preferred for high-grade analyses due to their superior chemical, biological, thermal, and physical properties. In this review, we highlight recent progress in commercially and semi-commercially available microfluidic devices based on glass and silicon substrates. We summarize key fabrication methods and their applications and examine how these platforms are advancing toward integrated readout, actuation, and sensing capabilities for a complete lab-on-a-chip system.

Identifiers

PMID41799908
PMCPMC12964201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.